Abstract
Introduction
Empirical and statistical design of experiments approaches are commonly used for selecting formulation and process parameters during the development of spray dried biologic products. An alternative approach is to use mechanistic models developed based on an understanding of fundamental underlying principles. That is the approach undertaken in this work wherein a dry powder bacteriophage (phage) dosage form is designed to have target characteristics without requiring a substantial number of spray drying experiments. The powder is intended for use in broiler chicken feed to decrease Campylobacter jejuni in the chicken gut, with the end goal of decreasing the prevalence of foodborne illness in Kenya, which is abnormally high. [1, 2] The development process can be divided into the following steps, discussed individually in this paper: 1) formulation; 2) atomization; 3) solvent evaporation and particle formation; 4) particle collection and analysis; 5) storage and transport.
Materials and Methods
A modified Büchi B-191 laboratory-scale spray dryer (Büchi Labortechnik AG; Flawil, Switzerland), schematically shown in Figure 1 , was used to spray dry different myoviridae phages that can infect Campylobacter jejuni: CP30A, CP20, and CP8. These phages were isolated from chicken excreta and are present in chicken gut. [3] A transmission electron micrograph (TEM) of phage CP20 is given in Figure 2 . 
Formulation
The formulations were chosen to consist of L-leucine (Fisher Scientific, Cat. No. AC125121000; NH, USA) and D-(+)-trehalose dihydrate (Fisher BioReagents, Cat. No. BP2687; NH, USA) as dissolved solids in aqueous solution with phage (pH ~6.5). Trehalose is thought to stabilize biologics on drying by forming an amorphous glass that allows hydrogen bonds lost on desiccation of the biologic to be replaced. [4] Leucine forms a shell that decreases particle cohesiveness. [5] For spray drying experiments, stock phage lysates were filtered and centrifuged to reduce the impurity content to < 0.5 mg mL -1 , and then diluted 1:100 into two aqueous formulations: (F1) 7.5 mg mL -1 leucine, 22.5 mg mL -1 trehalose; (F2) 12 mg mL -1 leucine, 18 mg mL -1 trehalose. In the literature similar formulations have been successfully used to stabilize spray dried phage. [6] [7] [8] [9] Further details regarding the choice of these formulations are given in the following sections. Plaque assay was used to measure the presence and extent of titer reduction due to dilution of phage into the above formulations. The results are presented in Section 3.1.
Atomization
The spray dryer uses a twin-fluid atomizer to generate droplets. An atomizing gas flow rate of 1.5×10 -4 kg s -1 and a spray rate of 1.7×10 -5 kg s -1 were used. A characteristic shear rate on the order of 1×10 5 s -1 was expected according to a model presented by Ghandi et al. [10] In the literature, [7] phage have remained active after atomization at similar shear rates. To verify minimal titer reduction, filtered phage CP30A lysate in formulation F1 was atomized onto a filter, from which liquid was drawn for assay. The results are presented in Section 3.2.
The air-to-liquid ratio (ALR), defined as the ratio of the mass flow rates of atomizing gas and liquid feed, was 8.8. From the ALR and data for the present atomizer given by Hoe et al., [11] an initial droplet diameter of ~9 µm was predicted. Using a model presented by
Boraey et al., [12] and the formulation compositions given in Section 2.1, the aerodynamic diameter at the time of shell formation was predicted to be ~2 µm, which can be collected with the cyclone.
Solvent Evaporation and Particle Formation
Solvent from the liquid droplets generated by atomization quickly evaporates into the drying chamber of the spray dryer. The surface temperature of the droplets is typically assumed to remain near the wet bulb temperature for most of the evaporation process due to evaporative cooling; [13] therefore, thermal deactivation of the phage is not expected during initial stages of solvent evaporation. The dissolved solid that reaches critical supersaturation at the surface first may nucleate and form a crystalline shell. This is the particle formation stage, which has been described by Vehring et al. [14] The formulation compositions in Section 2.1 were designed using mechanistic models such that leucine would reach supersaturation much earlier than trehalose, allowing for enough time to nucleate and crystallize leucine at the surface (11.5 milliseconds for F1 and 15.8 milliseconds for F2). Since previous work has demonstrated that conditions similar to F1 may not be sufficient for obtaining a fully crystalline leucine structure when phage lysate is present in the formulation, F2 was also tested with the expectation that it would form a fully crystalline leucine structure. [9] A spray dryer process model, developed based on similar models in the literature, [15, 16] was used to predict the outlet temperature and the outlet relative humidity. The outlet temperature was predicted to be ~50°C and the outlet relative humidity ~3% for an inlet temperature of 70°C, a spray rate of 1.7×10 -5 kg s -1 , and a drying gas flow rate of 8.5×10 -3 kg s -1 .
Particle Collection and Analysis
A cyclone was used to collect the powder in a glass collection bottle. The collection efficiency is defined as the percent of the mass of dissolved solids in the feed solution recovered in the collection bottle. The collected powder containing phage was analyzed for solid state using Raman spectroscopy (using a custom device developed by Wang et al. [17] ) and for particle morphology using scanning electron microscopy (SEM) (Zeiss Sigma FESEM, Oberkochen, Germany). Results are presented in Section 3.4.
Storage and Transport
Moisture uptake during storage and transport can result in crystallization of trehalose, which is known to deactivate phage. [18] Therefore, it is crucial that the packaging material is moisture-equilibrated. In this study, a Steady State / Stability Test Chamber (910W-4, Lunaire Environmental, Williamsport, PA, USA) was used to equilibrate the powder and packaging to 4% relative humidity, with subsequent packaging occurring in the chamber.
The relative humidity was chosen according to moisture uptake data and the information contained in Figure 3 , described below. The packaging consisted of the powder in a vial, which was packaged in a double heat-sealed aluminum foil bag along with a satchel of silica gel desiccant (McMaster Carr, 2189K16; Elmhurst, USA), all of which were further packaged in another double heat-sealed aluminum foil bag along with another satchel of silica gel desiccant. The packaged spray dried powder, along with liquid controls, were shipped from Edmonton, Canada, to Nottingham, UK, in a Styrofoam box to minimize temperature variations. The titer after the complete development and shipping process will be determined by resuspension of the powder and plaque assay.
Throughout long-term stability studies, the powder should remain at a near-constant moisture content as, over time, moisture can lead to glass transition and crystallization. This tendency is demonstrated in a supplemented phase diagram that was developed for a trehalose-water system and is shown in Figure 3 . With this diagram, the physical stability of the amorphous solid phase can be predicted a priori for a designed storage temperature, moisture content, and hence relative humidity. Use of this diagram is crucial for achieving long-term physical stability. The curve of the well-mixed glass transition temperature was developed using the Gordon-Taylor equation with a k-value of 5.9 and respective glass transition temperatures of 387 K for dry trehalose and 138 K for water. [19] As a rule of thumb, long-term storage should be performed for conditions at least 50°C below the glass transition temperature. [20] Fig. 3 Supplemented phase diagram developed for a trehalose-water system. Modified from Hoe et al. [21] with the present process parameters and material properties.
Results and Discussion

Formulation
Filtered phage CP30A lysate had no titer reduction over a period of 20 days when stored at 30°C in water, buffer, or formulation F1. A storage temperature of 40°C led to no titer reduction in buffer after 1 day but to > 1 log(pfu/mL) titer reduction after 10 days. A storage temperature of 50°C led to no titer reduction in buffer for at least 6 hours. No titer reduction was observed shipping CP30A in F1 within a vial in a Styrofoam box without temperature control from Nottingham, UK, to Edmonton, Canada, and back. This stability indicated that it is feasible to perform liquid control measurements with each experiment.
Atomization
The atomization titer reduction of phage CP30A in F1 was ~0.25 log(pfu/mL), which is less than the value of ~0.75 log(pfu/mL) reported in the literature for phages PEV2 and PEV40, [7] where similar predicted shear rates were used.
Solvent Evaporation and Particle Formation
The outlet temperature matched predictions from the process model within 2°C.
Particle Collection and Analysis
The collection efficiency was 54% for both formulations, which is typical for nominal batch sizes of ~1.5 grams. Raman spectroscopy confirmed trehalose was amorphous while leucine was mostly crystalline for both formulations. SEM (Figure 4 ) indicated that the phage lysate affected the particle morphology. It is possible that residual components in the phage lysate concentrated on the surface and interfered with the sensitive shell deformation and crystallization processes. This morphology was also present for other phage spray dried with leucine and trehalose in the literature, for which good powder flowability and longterm biological stability at 20°C were still achieved. [9] Fig. 4 SEM of spray dried F1 without (left) and with (right) phage CP20. The same scale bar applies to both images.
Storage and Transport
The supplemented phase diagram in Figure 3 suggests that the developed powder will have long-term physical stability without the need for refrigeration when a low relative humidity is maintained in the packaging. The biological stability of the phage in the powder during storage and transport will be determined.
Conclusions
Mechanistic models were used to select formulation and spray drying process parameters for stabilizing phage. Further results will be presented at the conference.
